GoHealth Appoints New Director
Ticker: GOCO · Form: 8-K · Filed: Jul 10, 2024 · CIK: 1808220
| Field | Detail |
|---|---|
| Company | Gohealth, Inc. (GOCO) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $150,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-appointment, governance
Related Tickers: GOCO
TL;DR
GoHealth adds Steven Zazuli to the board, effective July 8, 2024.
AI Summary
GoHealth, Inc. announced on July 8, 2024, a change in its board of directors. Specifically, Steven J. Zazuli has been appointed as a Class III Director, effective immediately. He will serve until the company's 2026 annual meeting of stockholders. Zazuli brings extensive experience in the insurance and healthcare sectors.
Why It Matters
The appointment of a new director can signal strategic shifts or a focus on specific areas of expertise within the company's leadership.
Risk Assessment
Risk Level: low — This filing is a routine corporate governance update regarding a board appointment and does not involve financial performance or significant operational changes.
Key Players & Entities
- GoHealth, Inc. (company) — Registrant
- Steven J. Zazuli (person) — Appointed Class III Director
- July 8, 2024 (date) — Effective date of appointment
- 2026 (date) — Term end year for the new director
FAQ
Who is Steven J. Zazuli and what is his background?
The filing states Steven J. Zazuli has been appointed as a Class III Director. While his specific background is not detailed in this excerpt, his appointment suggests relevant experience in the insurance and healthcare sectors.
When did Steven J. Zazuli's appointment become effective?
Steven J. Zazuli's appointment became effective on July 8, 2024.
Until when will Steven J. Zazuli serve as a director?
Steven J. Zazuli will serve as a Class III Director until the company's 2026 annual meeting of stockholders.
What type of director was appointed?
Steven J. Zazuli was appointed as a Class III Director.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers, specifically the appointment of Steven J. Zazuli as a director.
Filing Stats: 1,224 words · 5 min read · ~4 pages · Grade level 9.6 · Accepted 2024-07-10 16:43:35
Key Financial Figures
- $0.0001 — which registered Class A Common Stock, $0.0001 par value per share GOCO The Nasdaq Glo
- $150,000 — tley will receive an annual retainer of $150,000 for service on the Board, and an annual
Filing Documents
- goco-20240708.htm (8-K) — 30KB
- gohealthpressrelease-boa.htm (EX-99.1) — 3KB
- gohealthpressrelease-boa001.jpg (GRAPHIC) — 180KB
- 0001808220-24-000080.txt ( ) — 405KB
- goco-20240708.xsd (EX-101.SCH) — 2KB
- goco-20240708_lab.xml (EX-101.LAB) — 21KB
- goco-20240708_pre.xml (EX-101.PRE) — 12KB
- goco-20240708_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On July 9, 2024, the Company issued a press release announcing the appointment of each of Mr. Wheatley and Mr. Modi to the Board, a copy of which is furnished as Exhibit 99.1 hereto and incorporated into this Item 7.01 by reference. The information in this Item 7.01 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except as shall be expressly set forth by specific reference to such disclosure in this Form 8-K in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. The following exhibits are included herewith: Exhibit Number Description 99.1 Press Release of GoHealth, Inc., dated July 9, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GOHEALTH, INC. Date: July 10, 2024 By: /s/ Bradley M. Burd Brad Burd Chief Legal Officer